Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer

• Chen Shao ,

  Contributed equally to this work with: Chen Shao, Chun-Peng Liao

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Department of Urology Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi, China

  ⨯
• Chun-Peng Liao ,

  Contributed equally to this work with: Chen Shao, Chun-Peng Liao

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America

  ⨯
• Peizhen Hu,

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America

  ⨯
• Chia-Yi Chu,

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America

  ⨯
• Lei Zhang,

  Affiliation Department of Epidemiology, Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi, China

  ⨯
• Matthew H. T. Bui,

  Affiliation Divsion of Urology- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Christopher S. Ng,

  Affiliation Divsion of Urology- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• David Y. Josephson,

  Affiliation Divsion of Urology- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Beatrice Knudsen,

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Translational Pathology and Biobank, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Mourad Tighiouart,

  Affiliation Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Hyung L. Kim,

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Divsion of Urology- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Haiyen E. Zhau,

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America

  ⨯
• Leland W. K. Chung ,

  * E-mail: Edwin.Posadas@scmc.edu (EMP); Ruoxiang.wang@cshs.org (RW); Leland.chung@cshs.org (LWKC)

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Division of Hematology Oncology-Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Ruoxiang Wang ,

  * E-mail: Edwin.Posadas@scmc.edu (EMP); Ruoxiang.wang@cshs.org (RW); Leland.chung@cshs.org (LWKC)

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Division of Hematology Oncology-Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯
• Edwin M. Posadas

  * E-mail: Edwin.Posadas@scmc.edu (EMP); Ruoxiang.wang@cshs.org (RW); Leland.chung@cshs.org (LWKC)

  Affiliations Uro-Oncolgy Research Laboratories, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Urologic Oncology Program, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, Los Angles, California, United States of America, Division of Hematology Oncology-Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

  ⨯